Evaluation of Adherence to the Mediterranean Diet in Patients with Recurrent Renal Stones and Disease Osteometabolic
1 other identifier
observational
50
1 country
1
Brief Summary
The aim of this research protocol is to evaluate the adherence to the Mediterranean diet in patients suffering from recurrent kidney stones and osteometabolic diseases. Results of the study will allow to assess the dietary habits of patients with the above diseases. Given the universal prevalence of nephrolithiasis and osteometabolic diseases, the knowledge of these data appears crucial for the proper management of the dietary approach to prophylaxis secondar
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Dec 2023
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 7, 2023
CompletedFirst Submitted
Initial submission to the registry
March 25, 2024
CompletedFirst Posted
Study publicly available on registry
March 11, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2026
ExpectedMarch 11, 2025
March 1, 2025
2.1 years
March 25, 2024
March 10, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Patient eating habits
Questionaries to detect the patients eating habits.
1-36 months
Eligibility Criteria
Patients with idiopathic relapsing nephrolithiasis with evidence instrumental of bilateral renal stones or emission of more than one stone in the past 5 years
You may qualify if:
- Patients with idiopathic relapsing nephrolithiasis with evidence instrumental of bilateral renal stones or emission of more than one stone in the past 5 years
You may not qualify if:
- Patients who had albumin-corrected plasma calcium levels \> 11.0 mg/dl at the time of the first determination of serum levels of 25 OH vitamin D;
- Patients who had glomerular filtration rate \< 60 mL/min/1.73 m2;
- Patients who had positive personal history of chronic granulomatous disease;
- pregnancy patients;
- Positive personal history for morphological abnormalities of the excretory system;
- incomplete data collection.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Irccs Synlab Sdn
Naples, 80143, Italy
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 25, 2024
First Posted
March 11, 2025
Study Start
December 7, 2023
Primary Completion
December 31, 2025
Study Completion (Estimated)
December 1, 2026
Last Updated
March 11, 2025
Record last verified: 2025-03